MedTrace Logo

Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder

NCT00467428 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2007-04-30

No results posted yet for this study

Summary

The purpose of the study is to investigate if NS2359 is effective in the treatment of ADHD in adult patients.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

NS2359

DRUG

Placebo

Sponsors & Collaborators

  • NeuroSearch A/S

    lead INDUSTRY

Principal Investigators

  • Thimothy Wilens, MD · Adult and Pediatric Psychopharmacology, Masschusetts General Hospial, Boston, US

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2004-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00467428 on ClinicalTrials.gov